Biotech · Private company · Wexford, PA, US
Neuronasal Inc
Track this companyFree. Adds Neuronasal Inc to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards1
- Circumventing the pharmacokinetic/pharmacodynamic limitations of antioxidant therapy for Parkinson's Disease by nose to brain delivery of N-acetylcysteineFiscal year 2024 · $478.2KNIH RePORTER 1R41AG087860-01 · fetched Nov 12, 2026